NCT01100112 - (CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release Tablets | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

August 31, 2010

Conditions

Colitis, Ulcerative

Interventions

DRUG

Budesonide

One Budesonide-MMX 9 mg tablet will be taken in the morning after breakfast for 8 weeks.

Trial Locations (15)

Santarus Clinical Investigational Site 9001, Andhra Pradesh

Santarus Clinical Investigational Site 9009, Andhra Pradesh

Santarus Clinical Investigational Site 9012, Andhra Pradesh

Santarus Clinical Investigational Site 9016, Andhra Pradesh

Santarus Clinical Investigational Site 9006, Assam

Santarus Clinical Investigational Site 9007, Gujarat

Santarus Clinical Investigational Site 9004, Karnataka

Santarus Clinical Investigational Site 9015, Karnataka

Santarus Clinical Investigational Site 9003, Kerala

Santarus Clinical Investigational Site 9002, Maharashtra

Santarus Clinical Investigational Site 9008, Maharashtra

Santarus Clinical Investigational Site 9013, Maharashtra

Santarus Clinical Investigational Site 9018, Rajasthan

Santarus Clinical Investigational Site 9005, Tamil Nadu

Santarus Clinical Investigational Site 9014, Uttar Pradesh